Spinal Muscular Atrophy (SMA) is a disease that causes motor neuron degeneration in the spinal cord and brainstem. The rarity of the disease has meant that the rate o...

CARB-X to fund the preclinical development and Phase I clinical trial of a novel OMPTA candidate. Polyphor today announced that it has been awarded a non-dilutive aw...

Newark, Delaware, February 4, 2019 – On the heels of recent FDA approvals of gene therapies in the US market, QPS, a GLP/GCP-compliant contract research organization ...

LEIDEN, the Netherlands, February 05, 2019 / -- ProteoNic Biotechnology BV announces that it licensed its 2G UNic™ technology for boosting recombinant protein product...

OXFORD and Nottingham UK, 06 FEBRUARY 2019: Pathios Therapeutics ("Pathios"), an innovative biotech company focused on the development of first in class therapies for...

Recently published study findings show Cellmid’s midkine antibodies prevented cardiac muscle damage and preserved cardiac function The research demonstrates that...

HERCULES, Calif.–February 7, 2019–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today an...

GOETTINGEN, Germany / GENEVA, Switzerland, February 08, 2019 / -- Andrew Alliance S.A. and Sartorius today announced the launch of the Andrew Alliance Pipette+ system...

OXFORD and Nottingham UK, 06 FEBRUARY 2019: Pathios Therapeutics ("Pathios"), an innovative biotech company focused on the development of first in class therapies for...

PCI expands bottling capacity Rockford, IL Commercial Packaging site to add nearly 100 mil...